Carmela Mendoza
Carmela Mendoza is a senior reporter for Private Equity International based in London. She first joined PEI in Hong Kong in 2015 and covered Asia. A graduate of Ateneo de Manila University, she previously worked for a digital agency in Singapore focused on government websites and publications covering business, trade and industry, transport, and social development.
With the end of the year upon us, we look back on the key events in private equity in China.
The transaction, made through CVC Asia Pacific Fund IV, is the firm’s fourth in Indonesia.
The investment in one of Japan’s leading retail broadcasters was made through Bain Capital Asia Fund II.
As the IMF predicts slower growth in China in 2016, the government is instituting reforms to push a consumer driven economy, which will provide opportunities for mid-market investors.
PE Access launched by Singaporean bank DBS is part of a trend in Asia and elsewhere, where increasing numbers of ultra high net worth individuals are seeking to broaden their portfolios by investing in private equity.
The new service addresses the increasing demand among the Indian private equity community to implement operational improvements in portfolio companies.
The firm sold its stake to an Indian subsidiary of Fairfax Holdings, raising Fairfax’s ownership in IIFL from 9 percent to up to 35 percent
Healthcare investor ChrysCapital sold its stake in Delhi-based pharmaceuticals company Mankind Pharma to investment firm Capital International for $200 million
The firm acquired HCP Packaging in 2012 through TPG Asia Partners V and has since grown the company to become the second biggest manufacturer of cosmetics packaging worldwide.
The fundraising took six months and closed in early December.